Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
The bone marrow is a frequent location of primary relapse after conventional cytotoxic drug treatment of human B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Because stromal cells have a major role in promoting chemotherapy resistance, they should be included to more realistically model in...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0258140&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841533134878801920 |
|---|---|
| author | Annie Luong Fabio Cerignoli Yama Abassi Nora Heisterkamp Hisham Abdel-Azim |
| author_facet | Annie Luong Fabio Cerignoli Yama Abassi Nora Heisterkamp Hisham Abdel-Azim |
| author_sort | Annie Luong |
| collection | DOAJ |
| description | The bone marrow is a frequent location of primary relapse after conventional cytotoxic drug treatment of human B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Because stromal cells have a major role in promoting chemotherapy resistance, they should be included to more realistically model in vitro drug treatment. Here we validated a novel application of the xCELLigence system as a continuous co-culture to assess long-term effects of drug treatment on BCP-ALL cells. We found that bone marrow OP9 stromal cells adhere to the electrodes but are progressively displaced by dividing patient-derived BCP-ALL cells, resulting in reduction of impedance over time. Death of BCP-ALL cells due to drug treatment results in re-adherence of the stromal cells to the electrodes, increasing impedance. Importantly, vincristine inhibited proliferation of sensitive BCP-ALL cells in a dose-dependent manner, correlating with increased impedance. This system was able to discriminate sensitivity of two relapsed Philadelphia chromosome (Ph) positive ALLs to four different targeted kinase inhibitors. Moreover, differences in sensitivity of two CRLF2-drivenBCP-ALL cell lines to ruxolitinib were also seen. These results show that impedance can be used as a novel approach to monitor drug treatment and sensitivity of primary BCP-ALL cells in the presence of protective microenvironmental cells. |
| format | Article |
| id | doaj-art-fb726bee2dec474d82344c0560cf0c59 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-fb726bee2dec474d82344c0560cf0c592025-01-17T05:32:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01169e025814010.1371/journal.pone.0258140Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.Annie LuongFabio CerignoliYama AbassiNora HeisterkampHisham Abdel-AzimThe bone marrow is a frequent location of primary relapse after conventional cytotoxic drug treatment of human B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Because stromal cells have a major role in promoting chemotherapy resistance, they should be included to more realistically model in vitro drug treatment. Here we validated a novel application of the xCELLigence system as a continuous co-culture to assess long-term effects of drug treatment on BCP-ALL cells. We found that bone marrow OP9 stromal cells adhere to the electrodes but are progressively displaced by dividing patient-derived BCP-ALL cells, resulting in reduction of impedance over time. Death of BCP-ALL cells due to drug treatment results in re-adherence of the stromal cells to the electrodes, increasing impedance. Importantly, vincristine inhibited proliferation of sensitive BCP-ALL cells in a dose-dependent manner, correlating with increased impedance. This system was able to discriminate sensitivity of two relapsed Philadelphia chromosome (Ph) positive ALLs to four different targeted kinase inhibitors. Moreover, differences in sensitivity of two CRLF2-drivenBCP-ALL cell lines to ruxolitinib were also seen. These results show that impedance can be used as a novel approach to monitor drug treatment and sensitivity of primary BCP-ALL cells in the presence of protective microenvironmental cells.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0258140&type=printable |
| spellingShingle | Annie Luong Fabio Cerignoli Yama Abassi Nora Heisterkamp Hisham Abdel-Azim Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence. PLoS ONE |
| title | Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence. |
| title_full | Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence. |
| title_fullStr | Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence. |
| title_full_unstemmed | Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence. |
| title_short | Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence. |
| title_sort | analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0258140&type=printable |
| work_keys_str_mv | AT annieluong analysisofacutelymphoblasticleukemiadrugsensitivitybychangesinimpedanceviastromalcelladherence AT fabiocerignoli analysisofacutelymphoblasticleukemiadrugsensitivitybychangesinimpedanceviastromalcelladherence AT yamaabassi analysisofacutelymphoblasticleukemiadrugsensitivitybychangesinimpedanceviastromalcelladherence AT noraheisterkamp analysisofacutelymphoblasticleukemiadrugsensitivitybychangesinimpedanceviastromalcelladherence AT hishamabdelazim analysisofacutelymphoblasticleukemiadrugsensitivitybychangesinimpedanceviastromalcelladherence |